Redx Pharma (REDX)

Sector:

Pharma and Biotech

8.75p
   
  • Change Today:
    -0.50p
  • 52 Week High: 36.00
  • 52 Week Low: 4.25
  • Currency: UK Pounds
  • Shares Issued: 388.99m
  • Volume: 119,658
  • Market Cap: £34.04m
  • RiskGrade: 278

Deal with Barclays    Trade now with Barclays Stockbrokers

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
97.31% below the market average97.31% below the market average97.31% below the market average97.31% below the market average97.31% below the market average
94.29% below the sector average94.29% below the sector average94.29% below the sector average94.29% below the sector average94.29% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
36.49% above the market average36.49% above the market average36.49% above the market average36.49% above the market average36.49% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
Price Book Ratio
93.23% below the market average93.23% below the market average93.23% below the market average93.23% below the market average93.23% below the market average
75.51% below the sector average75.51% below the sector average75.51% below the sector average75.51% below the sector average75.51% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
98.34% below the market average98.34% below the market average98.34% below the market average98.34% below the market average98.34% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Chg 3m
95.72% below the market average95.72% below the market average95.72% below the market average95.72% below the market average95.72% below the market average
85.96% below the sector average85.96% below the sector average85.96% below the sector average85.96% below the sector average85.96% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
49.11% below the market average49.11% below the market average49.11% below the market average49.11% below the market average49.11% below the market average
43.4% below the sector average43.4% below the sector average43.4% below the sector average43.4% below the sector average43.4% below the sector average
Momentum 20
76.86% below the market average76.86% below the market average76.86% below the market average76.86% below the market average76.86% below the market average
73.58% below the sector average73.58% below the sector average73.58% below the sector average73.58% below the sector average73.58% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
89.42% below the market average89.42% below the market average89.42% below the market average89.42% below the market average89.42% below the market average
45.95% below the sector average45.95% below the sector average45.95% below the sector average45.95% below the sector average45.95% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
83.45% below the market average83.45% below the market average83.45% below the market average83.45% below the market average83.45% below the market average
59.26% below the sector average59.26% below the sector average59.26% below the sector average59.26% below the sector average59.26% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
59.34% below the market average59.34% below the market average59.34% below the market average59.34% below the market average59.34% below the market average
18.92% below the sector average18.92% below the sector average18.92% below the sector average18.92% below the sector average18.92% below the sector average
Operating Profit Loss
91.12% below the market average91.12% below the market average91.12% below the market average91.12% below the market average91.12% below the market average
85.19% below the sector average85.19% below the sector average85.19% below the sector average85.19% below the sector average85.19% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
4.84% below the market average4.84% below the market average4.84% below the market average4.84% below the market average4.84% below the market average
24.53% above the sector average24.53% above the sector average24.53% above the sector average24.53% above the sector average24.53% above the sector average
Cash
25.73% above the market average25.73% above the market average25.73% above the market average25.73% above the market average25.73% above the market average
37.04% above the sector average37.04% above the sector average37.04% above the sector average37.04% above the sector average37.04% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
21.59% below the market average21.59% below the market average21.59% below the market average21.59% below the market average21.59% below the market average
29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
39.21% above the market average39.21% above the market average39.21% above the market average39.21% above the market average39.21% above the market average
68.42% above the sector average68.42% above the sector average68.42% above the sector average68.42% above the sector average68.42% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Redx Pharma Market Data

Currency UK Pounds
Share Price 8.75p
Change Today -0.50p
% Change -5.41 %
52 Week High 36.00
52 Week Low 4.25
Volume 119,658
Shares Issued 388.99m
Market Cap £34.04m
RiskGrade 278

Redx Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
59.63% below the market average59.63% below the market average59.63% below the market average59.63% below the market average59.63% below the market average
84.91% below the sector average84.91% below the sector average84.91% below the sector average84.91% below the sector average84.91% below the sector average
Price Trend
94.27% below the market average94.27% below the market average94.27% below the market average94.27% below the market average94.27% below the market average
92.98% below the sector average92.98% below the sector average92.98% below the sector average92.98% below the sector average92.98% below the sector average
Income Not Available
Growth
28.94% below the market average28.94% below the market average28.94% below the market average28.94% below the market average28.94% below the market average
45.95% below the sector average45.95% below the sector average45.95% below the sector average45.95% below the sector average45.95% below the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Redx Pharma Dividends

No dividends found

Trades for 25-Apr-2024

Time Volume / Share Price
10:51 2,475 @ 8.58p
10:35 187 @ 8.02p
10:04 28 @ 8.02p
10:03 338 @ 8.02p
10:02 96 @ 8.02p

Top of Page